•Patient’s healthcare provider must start the enrollment process by submitting the request form (https://www.astellaspharmasupportsolutions.com/docs/cresemba/CRESEMBA_Patient_Enrollment_Form.pdf)
•HCP can also enroll patients by logging into Astellas eService; HCP must complete the patient enrollment form, print to obtain all HCP and patient signatures then upload through eService or fax to 18663176235
•Patient MUST read and sign the Patient Authorization Statement on pages 35 and sign on page 1
•Evaluation of program criteria is patientspecific and retrospective to treatment
•Once approved, patient, provider, and pharmacy will be notified
•Patient will receive initial 28day supply of medication within 2 to 5 days of approval notification
•For all subsequent shipments, CRESEMBA Support Solutions will contact physician to confirm patient requires continued therapy
•If so, the Astellas designated pharmacy will contact the patient to arrange for shipment and dispense up to a 28day supply of CRESEMBA at a time per the physician's prescription
•For more information call 18004776472, MondayFriday 9am8pm ET